Salmedix logo

Salmedix

Pioneering advanced treatments for blood cancers, delivering innovative Phase II clinical trials with a focus on patient health and care

est. 2000

VS
Tethis S.p.A logo

Tethis S.p.A

31 employees · est. 2004 · Milano, Italy

Salmedix is the older company (2000 vs 2004).

Side-by-Side Comparison

Salmedix Tethis S.p.A
Founded
2000 older 2004
Headquarters
Not tracked yet Milano, Italy
Employees
Not tracked yet 31
Industry
Biotechnology, Health Care Biotechnology
Funding Stage
Series C Grant
Total Funding
$72.50M $71.43K
Funding Rounds
3 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Oncology, Blood Cancers, Phase II Clinical Trials, Hematologic Malignancies, Drug Development, SDX-105, Healthcare Professionals, Germany, U.S., Canada, SDX-101, SDX-102, Clinical-Stage Product Candidates, David Kabakoff, San Diego Liquid Biopsy, Oncology Diagnostic, Proprietary Slides, Blood Samples Processing, Clinical Informativity, High Throughput Analytical Protocols, Cancer Testing, Clinical Settings
Website
salmedix.com tethis-lab.com
Salmedix logo

About Salmedix

Founded in 2000 by David Kabakoff, Salmedix is a pioneer in oncology drug development, focusing on treatments for hematologic malignancies. The company's primary product, SDX-105, has been made available in Germany to address various blood cancers, and is currently undergoing Phase II clinical trial...

Tethis S.p.A logo

About Tethis S.p.A

Tethis S.p.A is a biotechnology startup based in Italy that was founded in 2004. The company aims to revolutionize oncology diagnostics by making liquid biopsy a standard, reproducible practice. Their proprietary slides enable immediate, fully automated, and gentle processing of blood samples, addre...

We will tell you when either one moves

BounceWatch watches Salmedix and Tethis S.p.A for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Salmedix and Tethis S.p.A — by email.

Frequently Asked Questions

Salmedix — Pioneering advanced treatments for blood cancers, delivering innovative Phase II clinical trials with a focus on patient health and care. Tethis S.p.A. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Salmedix has raised $72.50M while Tethis S.p.A has raised $71.43K.
Salmedix and Tethis S.p.A operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Salmedix with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Salmedix on 12 Sep 2024, and Tethis S.p.A on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy